RxDoctor Payments Data

Carley Fowler, MD

Dermatology · Knoxville, TNNPI 1619204476

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Novartis accounts for 69.1% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $18,293 and has fallen 91.1% since, to $1,620 in 2025. Among dermatology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,973in general payments, 2019–2025

Across 492 payments — averaging $54.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$19K
  • AbbVie$2K
  • Sun Pharmaceutical Industries Inc.$849
  • UCB, Inc.$794
  • Lilly USA, LLC$674
  • Sanofi$626
  • plus $4K from 27 others

What the payments were for

  • Speaking & faculty fees$15,00056%
  • Travel & lodging$2,1618%
  • Food & beverage$9,61636%
  • Education$1961%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,973 in reported general payments places this provider in the 90th percentile of 209 dermatology providers in Tennessee.

See all dermatology providers in Tennessee

Medicare billing

Part B allowed, 2024
$281,310
Medicare patients
751
Services billed
5,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab15$122,154
Dupixent SyringeDupilumab11$56,758
Dupixent PenDupilumab14$52,414
Fluorouracil91$6,012
Betamethasone Dipropionate91$3,736
Clobetasol Propionate41$3,387
Metronidazole57$2,915
Ketoconazole104$1,592
Triamcinolone Acetonide90$1,506
Tretinoin14$1,341
Doxycycline Hyclate51$1,122
Fluocinonide20$814
Hydrocortisone77$685
Azelaic Acid12$658
Spironolactone51$638

Paid to pharmacies, not to this prescriber.

Other dermatology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →